Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CYTKCYTK
Showing 8 of 29 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CYTOKINETICS INC

NORTHERN TRUST CORP holds 1.4M shares of CYTK (CYTOKINETICS INC), worth $95M as of 2026-Q1. The position was increased (+4.4% shares). CYTK represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$95M

Current Shares

1.4M

Total Value Change

+$25.5M

Total Shares Change

+158,741

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.4M
+4.4%
$95M0.0%$60.72
31
2025-Q4
Decreased
1.4M
-1.9%
$87.7M0.0%$61.37
0
2025-Q3
Increased
1.4M
+2.0%
$77.3M0.0%$53.89
30
2025-Q2
Decreased
1.4M
-4.7%
$45.6M0.0%$33.16
0
2025-Q1
Decreased
1.4M
-1.6%
$58.2M0.0%$43.19
0
2024-Q4
Increased
1.5M
+10.7%
$69.2M0.0%$47.15
33
2024-Q3
Increased
1.3M
+3.6%
$70.2M0.0%$52.34
31
2024-Q2
Increased
1.3M
+15.4%
$69.5M0.0%$54.18
34

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used